GlassScriptPhysician profile
Thao P Nguyen
NPI 1881794824
$1,724.51
in general payments reported to CMS, 2019-2025
24 companies · $50.43 in 2025
The $50.43 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $493 · 2022: $477 · 2023: $369 · 2024: $336 · 2025: $50.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $292.94 | 2021-2023 | Farxiga |
| Lilly USA, LLC | $240.57 | 2021-2024 | Omvoh, Jardiance, Zepbound |
| Novo Nordisk INC | $207.31 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.66 | 2021-2024 | Jardiance, Synjardy |
| Abbott Laboratories | $107.42 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $93.89 | 2021-2024 | Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $78.82 | 2024 | Voquezna |
| Abbvie INC. | $76.11 | 2021-2022 | |
| Insulet Corporation | $58.91 | 2022-2023 | Omnipod |
| Sanofi-Aventis U.S. LLC | $58.77 | 2022-2023 | |
| Medtronic, INC. | $55.44 | 2021-2023 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Pfizer INC. | $49.61 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $42.88 | 2021 | |
| Dexcom, INC. | $42.02 | 2022-2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $39.06 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $31.27 | 2021-2022 | |
| Embecta Corp. | $27.72 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Abiomed | $27.07 | 2025 | |
| Beta Bionics, INC. | $15.93 | 2023 | Ilet Bionic Pancreas |
| Zealand Pharma US, INC. | $15.13 | 2021 | |
| Radius Health, INC. | $13.83 | 2024 | Tymlos |
| Mannkind Corporation | $13.37 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.45 | 2022 | |
| Cequr Corporation | $4.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thao Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.